Chief Commercial Officer
Don O’Neil has over 20 years of relevant life sciences experience. His previous roles include responsibilities for Invitrogen’s global reagents business, now owned by Thermo Fisher, and MilliporeSigma’s Cell Biology and Detection Solutions business segments. He was most recently senior vice president of sales and Strategic Partnerships at ORFLO Technologies, a life science instruments company. He leads Gemini’s commercial efforts across the sales and marketing team.